UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 305-509-6897 (Registrant's Telephone Number, Including Area Code) FORM 10-Q (Mark One) Commission File Number 1-13602 | | | (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) N/A (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) Securities registered pursuant to Section 12(b) of ...

Veru Inc. (NASDAQ:VERU) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations & Corporate Communications Mitchell Steiner - Chairman, Chief Executive Officer & President Michele Greco - Chief Financial Officer & Chief Accounting Officer Conference Call Participants Yi Chen - H.C. Wainwright Brandon Folkes - Cantor Fitzgerald Operator Good morning, ladies and gentlemen, and welcome to Veru Inc. Investor Conference Call. All participan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 (State of Incorporation) (I.R.S. Employer Identification No.) 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) 305-509-6897 (Registrant's Telephone Number, Including Area Code) N/A (Former Name, Former Address and Former Fiscal Year, if Changed Sinc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13602 Veru Inc. (Name of registrant as specified in its charter) | Wisconsin 39-1144397 | | | --- | --- | | (State or other jurisdiction ...

Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Conference Call December 5, 2022 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations, and Corporate Communications Mitchell Steiner - Chairman, Chief Executive Officer and President Michele Greco - Chief Financial Officer and Chief Administrative Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland Gershell - Oppenheimer Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Operator Good morning, ladies and gent ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Biopharmaceutical Company focused on Infectious Disease and Oncology | | | | | Veru Corporate Presentation Cantor Oncology, Hematology & HemeOnc Conference September 28, 2022 | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 (Registrant's Telephone Number, Including Area Code) N/A (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) Securities registered pursuant to Section 12(b) of the Act: 2916 N. Miami Avenue, Suite 1000, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) ...

Veru Inc. (NASDAQ:VERU) Q3 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, IR & Corporate Communications Mitchell Steiner - Chairman, President & CEO Michele Greco - CFO & Chief Administrative Officer Gary Barnette - Chief Scientific Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland Gershell - Oppenheimer Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome t ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | | | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this release include statements regarding: whether and when the Company will submit an EUA application, or receive an emergency use authorization or any approval from F ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | Biopharmaceutical Company Focused on COVID-19 and Oncology | | | | | Veru Corporate Presentation H.C. Wainwright Global Investment Conference May 23-26, 2022 | | | | Forward looking statements The statements in this release that are not historical facts are "forward-looking statements" as that term is defined in the Private Securitie ...